摘要
背景:荟萃分析表明,非偶联铜的比例——铜是不绑定到铜蓝蛋白(也被称为“自由”铜)在血清中高于阿尔茨海默病(AD)患者中。阿尔茨海默病遗传异质性在非偶联铜截止的基础上维持一个铜的阿尔茨海默病代谢亚型的存在。非偶联铜异常与脑电节律(EEG)的改变有关。 目的:我们的目的是,分层在一个铜标记基础上,确定是否一个脑电节律的异质性两个阿尔茨海默病组,。 方法:我们评估铜的水平,铜蓝蛋白,非偶联铜,和APOE4基因型在67例阿尔茨海默病患者较于静息脑电节律衍生eLORETA 皮质节律,就''正常''和''高''非偶联铜之间分组阿尔茨海默病。 结果:高非偶联铜组经历了在所有波段的较低功率(0.2-48 Hz)在顶叶皮层(P = 0.019)和更有限的α波(8-13 Hz)在感觉器官(颞、枕叶的力量,和顶叶P<0.05一致)比正常非偶联铜阿尔茨海默病组。校正后的MMSE,伴随高频脑活动非偶联铜含量的减少(从高α-γ,10.5-48 Hz) 结论:脑皮质脑电图衍生节奏两阿尔茨海默病组之间的电生理异质性支撑铜自代谢亚型;非偶联铜是铜在阿尔茨海默病的一个标记
关键词: 阿尔茨海默病(AD)的亚型,血清铜蓝蛋白、皮质脑电图(EEG),叶,游离铜
Current Alzheimer Research
Title:Non-Ceruloplasmin Copper Distinguishes A Distinct Subtype of Alzheimer’s Disease: A Study of EEG-Derived Brain Activity
Volume: 13 Issue: 12
Author(s): Franca Tecchio, Fabrizio Vecchio, Mariacarla Ventriglia, Camillo Porcaro, Francesca Miraglia, Mariacristina Siotto and Paolo M. Rossini, Mauro Rongioletti, Rosanna Squitti
Affiliation:
关键词: 阿尔茨海默病(AD)的亚型,血清铜蓝蛋白、皮质脑电图(EEG),叶,游离铜
摘要: Background: Meta-analyses show that percentages of non-Cp-Cu—copper that is not bound to ceruloplasmin (also known as ‘free’ copper)—in serum are higher in Alzheimer’s disease (AD) patients. Genetic heterogeneity in AD patients stratified on the basis of non-Cp-Cu cut-off sustains the existence of a copper AD metabolic subtype. Non-Cp-Cu abnormalities correlated with alterations of electroencephalographic rhythms (EEG).
Objective: We aimed to determine whether an EEG-derived brain cortical rhythm’s heterogeneity between two AD groups stratified on the basis of a copper marker.
Method: We assessed levels of copper, ceruloplasmin, Non-Cp-Cu, and the APOE4 genotype in 67 AD patients and compared resting EEG-derived eLORETA cortical rhythms between AD groups stratified in terms of ‘Normal’ and ‘High’ non-Cp-Cu.
Results: The High non-Cp-Cu group experienced a lower power in all bands (0.2-48 Hz) in the parietal cortices (p=0.019) and a more limited alpha band (8-13 Hz) power in the sensory lobes (temporal, occipital, and parietal p<0.05 consistently) than the Normal non-Cp-Cu AD group. When corrected for MMSE, the non-Cp-Cu levels correlated with a reduction of high-frequency brain activity (from high alpha to gamma, 10.5-48 Hz).
Conclusion: This neurophysiological heterogeneity in EEG-derived brain cortical rhythms between the two AD groups sustains a copper AD metabolic subtype; Non-Cp-Cu is a marker of this copper AD.
Export Options
About this article
Cite this article as:
Franca Tecchio, Fabrizio Vecchio, Mariacarla Ventriglia, Camillo Porcaro, Francesca Miraglia, Mariacristina Siotto and Paolo M. Rossini, Mauro Rongioletti, Rosanna Squitti , Non-Ceruloplasmin Copper Distinguishes A Distinct Subtype of Alzheimer’s Disease: A Study of EEG-Derived Brain Activity, Current Alzheimer Research 2016; 13 (12) . https://dx.doi.org/10.2174/1567205013666160603001131
DOI https://dx.doi.org/10.2174/1567205013666160603001131 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Biological Signatures of Alzheimer’s Disease
Current Topics in Medicinal Chemistry P-gp Transporter and its Role in Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Inflammation: Beneficial or Detrimental After Spinal Cord Injury?
Recent Patents on CNS Drug Discovery (Discontinued) Exploring the Mechanism of Lingzhu San in Treating Febrile Seizures by Using Network Pharmacology
Combinatorial Chemistry & High Throughput Screening Therapeutic Targets in Prostaglandin E2 Signaling for Neurologic Disease
Current Medicinal Chemistry Recent Advances in the Synthesis of 1,3-Azoles
Current Topics in Medicinal Chemistry Novel S-Nitrosothiols Have Potential Therapeutic Uses for Cystic Fibrosis
Current Pharmaceutical Design Proteomics Approaches to Understand Linkage Between Alzheimer’s Disease and Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Neurotrophic Factors as a Protective Strategy in Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Alkaloids from Cyanobacteria with Diverse Powerful Bioactivities
Mini-Reviews in Medicinal Chemistry Therapeutic Strategies To Prevent Neurodegeneration And Promote Regeneration In Multiple Sclerosis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Dimebon Attenuates the Aβ-Induced Mitochondrial Permeabilization
Current Alzheimer Research Cell-based Treatment of Cerebral Palsy: Still a Long Way Ahead
Current Stem Cell Research & Therapy Gene-Gene and Gene-Environment Interaction on the Risk of Parkinson’s Disease
Current Aging Science Neurotoxicity by Synthetic Androgen Steroids: Oxidative Stress, Apoptosis, and Neuropathology: A Review
Current Neuropharmacology Targeting Kynurenine 3-Monooxygenase (KMO): Implications for Therapy in Huntingtons Disease
CNS & Neurological Disorders - Drug Targets p53-Induced Apoptosis and Inhibitors of p53
Current Medicinal Chemistry Vascular Endothelial Growth Factor in Central Nervous System Injuries – A Vascular Growth Factor Getting Nervous?
Current Neurovascular Research The Role of Autophagy on the Survival of Dopamine Neurons
Current Topics in Medicinal Chemistry